Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: Is it a new urinary activity marker?

Nephrology

Volumn 8, Issue 5, 2003, Pages 231-238

  Evereklioglu, Cem ^a,c   Özbek, Emin ^b   Çekmen, Mustafa ^b   Mehmet, Nihayet ^b   Duygulu, Fuat ^a   Ozkiris, Abdullah ^a   Çalip, Mustafa ^a   Er, Hamdi ^b   Türköz, Yusuf ^b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Activity; Beh et's disease; Nitric oxide; Urine

Indexed keywords

BIOCHEMICAL MARKER; CREATININE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; BEHCET DISEASE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DISEASE ACTIVITY; DISEASE MARKER; EVALUATION; FEMALE; HUMAN; INFLAMMATION; KIDNEY; MALE; PRIORITY JOURNAL; URINALYSIS; URINE LEVEL;

ADULT; BEHCET SYNDROME; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CASE-CONTROL STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; NITRIC OXIDE; NITRITES; PREDICTIVE VALUE OF TESTS; UP-REGULATION;

EID: 0242490190     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2003.00180.x     Document Type: Article

References (47)

1. Onder M, Gurer MA. The multiple faces of Behçet's disease and its aetiological factors. J. Eur. Acad. Dermatol. Venereol. 2000; 15: 126-36.
2. Hirohata T, Kuratsune M, Nomura A, Jimi S. Prevalence of Behçet's disease in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan. Hawaii Med. J. 1975; 34: 244-6.
3. Behçet H. Uber rezidivierende Aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol. Wochenschr 1937; 105: 1152-7 (In German with an English abstract).
4. Evereklioglu C, Er H. Increased corneal thickness in active Behçet's disease. Eur. J. Ophthalmol. 2002; 12: 24-9.
5. Evereklioglu C, Cokkeser Y, Doganay S, Er H, Kizilay A. Audio-vestibular evaluation in patients with Behçet's syndrome. J. Laryngol. Otol. 2001; 115: 704-8.
6. Evereklioglu C, Ozbek E, Er H, Cekmen M, Yurekli M. Urinary adrenomedullin levels are increased and correlated with plasma concentrations in patients with Behçet's syndrome. Int. J. Urol. 2002; 9: 296-303.
7. Gunen H, Evereklioglu C, Kosar F, Er H, Kizkin O. Thoracic involvement in Behçet's disease and its correlation with multiple parameters. Lung 2000; 178: 161-70.
8. Kilmartin DJ, Finch A, Acheson RW. Primary association of HLA-B51 with Behçet's disease in Ireland. Br. J. Ophthalmol. 1997; 81: 649-53.
9. Farrell AJ, Blake DR. Nitric oxide. Ann. Rheum. Dis. 1996; 55: 7-20.
10. Moshage H. Nitric oxide determinations: Much ado about NO.-thing? Clin. Chem. 1997; 43: 553-6.
11. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J. Clin. Invest. 1993; 91: 2012-19.
12. Olsson PJ, Gaffney E, Alexander RW, Mars DR, Fuller TJ. Proliferative glomerulonephritis with crescent formation in Behçet's syndrome. Arch. Intern. Med. 1980; 140: 713-14.
13. Finucane P, Doyle CT, Ferriss JB, Molloy M, Murnaghan D. Behçet's syndrome with myositis and glomerulonephritis. Br. J. Rheumatol. 1985; 24: 372-5.
14. Yver L, Blanchier D, Aouragh F et al. Renal involvement in Behçet's disease. Case report and review of the literature. Nephron 1996; 73: 689-91.
15. El Ramahi KM, Al Dalaan A, Al Shaikh A, Al Meshari K, Akhtar M. Renal involvement in Behçet's disease: review of 9 cases. J. Rheumatol. 1998; 25: 2254-60.
16. Yang CW, Park IS, Kim SY et al. Antineutrophil cytoplasmic autoantibody associated vasculitis and renal failure in Behçet's disease. Nephrol. Dial. Transplant. 1993; 8: 871-3.
17. Evereklioglu C, Yurekli M, Er H et al. Increased plasma adrenomedullin levels in patients with Behçet's disease. Dermatology 2000; 201: 312-15.
18. Evereklioglu C, Inaloz HS, Kirtak N et al. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Br. J. Dermatol. 2002; 147: 331-6.
19. Er H, Evereklioglu G, Cumurcu T et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Br. J. Ophthalmol. 2002; 86: 653-7.
20. Evereklioglu C, Er H, Turkoz Y, Cekmen M. Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Med. Inflamm. 2002; 11: 87-93.
21. Erkilic K, Evereklioglu C, Cekmen M, Ozkiris A, Duygulu F, Dogan H. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations. Mediators Inflamm. 2003; 12: 107-16.
22. Turkoz Y, Evereklioglu C, Mehmet N, Cekmen M, Er H. Plasma malondialdehyde levels in Behçet's disease with or without ocular involvement. Adv. Reprod. 2000; 4: 31-6.
23. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker? J. Am. Acad. Dermatol. 2002; 46: 50-4.
24. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335; 1078-80.
25. Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Meth. Enzymol. 1996; 268: 142-51.
26. Er H, Doganay S, Turkoz Y et al. The levels of cytokines and nitric oxide in rabbit vitreous humor after retinal laser photocoagulation. Ophthalmic. Surg. Lasers 2000; 31: 479-83.
27. Doganay S, Evereklioglu C, Turkoz Y, Er H. Decreased nitric oxide production in primary open-angle glaucoma. Eur. J. Ophthalmol. 2002; 12: 44-8.
28. Evereklioglu C, Er H, Doganay S et al. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc. Ophthalmol. 2003; 106: 129-36.
29. Onder M, Bozkurt M, Gurer MA, Gulekon A, Sezgin P, Imir T. Natural cellular cytotoxicity in Behçet's disease. J. Dermatol. 1994; 21: 239-43.
30. Karlidag R, Unal S, Evereklioglu C, Sipahi B, Er H, Yologlu S. Stressful life events, anxiety, depression and coping mechanisms in patients with Behçet's disease. J. Eur. Acad. Dermatol. Venereal. 2003; in press.
31. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109-42.
32. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 1994; 269: 13 725-8.
33. Ochoa JB, Udekwu AO, Billiar TR et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 1991; 214: 621-6.
34. Kiraz S, Ertenli I, Calguneri M et al. Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin. Exp. Rheumatol. 2001; 19: 25-9.
35. Atalay G, Eksioglu-Demiralp E, Akoglu T, Direskeneli H. The effects of nitric oxide donors and inhibitors on neutrophil functions in Behçet's disease. Clin. Exp. Rheumatol. 2002; 20: 17-20.
36. Sancak B, Onder M, Oztas MO, Bukan N, Gurer MA. Nitric oxide levels in Behçet's disease. J. Eur. Acad. Dermatol. Venereal. 2003; 17: 7-9.
37. Yilmaz G, Sizmaz S, Yilmaz ED, Duman S, Aydin P. Aqueous humor nitric oxide levels in patients with Behçet's disease. Retina 2002; 22: 330-5.
38. Salvarani C, Boiardi L, Casali B et al. Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J. Rheumatol. 2002; 29: 535-40.
39. Narita I, Border WA, Ketteler M, Noble NA. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab. Invest. 1995; 72: 17-24.
40. Markewitz BA, Michael JR, Kohan DE. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J. Clin. Invest. 1993; 91: 2138-43.
41. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc. Nad Acad. Sci. USA 1993; 90: 3645-9.
42. Inaloz HS, Evereklioglu C, Deveci E et al. The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome. J. Eur. Acad. Dermatol. Venereol. 2003; in press.
43. Kwon OH, Kim HS, Kim DS. Relationship of circulating immune complex levels with clinical activity in Behçet's disease. In: O'Duffy, JD Kokmen, E, eds. Behçet's Disease: Basic and Clinical Concepts. New York: Marcel Dekker, 1991; 355-60.
44. Malik GH, Sirwal IA, Pandit KA. Behçet's syndrome associated with minimal change glomerulonephritis and renal vein thrombosis. Nephron 1989; 52: 87-9.
45. Koyama A, Niwa Y, Shigematsu H, Taniguchi M, Tada T. Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus. Lab. Invest. 1978; 38; 253-62.
46. Sugo S, Minamino N, Kangawa K et al. Endothelial cells actively synthesize and secrete Adrenomedullin. Biochem. Biophys. Res. Commun. 1994; 201; 1160-6.
47. Yang BC, Lippton H, Gumusel B, Hyman A, Mehta JL. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J. Cardiovasc. Pharmacol. 1996; 28: 458-62.